MyAverix Finance
F · Healthcare
Applied Therapeutics Inc (2UV)
Biotechnology
Applied Therapeutics Inc (2UV) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-31, reported market cap is $11.10M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2UV
Applied Therapeutics Inc (2UV) — FAQ
What is Applied Therapeutics Inc's market cap?
Applied Therapeutics Inc (2UV) has a reported market cap of $11.10M (data as of 2026-03-31).
What is 2UV's P/E ratio?
The price-to-earnings (P/E) ratio for Applied Therapeutics Inc (2UV) is 18.00 (data as of 2026-03-31).
Does Applied Therapeutics Inc pay a dividend?
Dividend yield is not available in the current snapshot for Applied Therapeutics Inc (2UV). Check the MyAverix Finance app for the latest dividend data.
What sector is Applied Therapeutics Inc in?
Applied Therapeutics Inc (2UV) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2UV listed on?
2UV is listed on F.
What is Applied Therapeutics Inc's net margin?
Applied Therapeutics Inc (2UV) reports a net margin of 0.0% (data as of 2026-03-31).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.